GFP-CARM1 plasmid was provided by Dr. Mark T. Bedford (University of Texas MD Anderson Cancer Center), and myc-PI3KC2α was provided by Dr. Emily Kim Malmberg (Biotech Research and Innovation Centre, University of Copenhagen). To generate deletion mutants of PI3KC2α, the fragmented polymerase chain reaction (PCR) products obtained from the full-length myc-PI3KC2α were cloned and inserted into the pGEX-6p-1 vector.
The following antibodies were used for Immunoblotting and immunoprecipitation: β-actin (Santa Cruz Biotechnology, Dallas, TX, USA, sc-47778), CARM1 (Bethyl Laboratories, Montgomery, TX, USA, A300-421A), Cyclin B1 (Cell Signaling Technology, Danvers, MA, USA, #12231), GFP (Santa Cruz Biotechnology, sc-9996), GST (Santa Cruz Biotechnology, sc-138), HA (Cell Signaling Technology, #3724), Histone H3 (Cell Signaling Technology, #9715), c-Myc (Santa Cruz Biotechnology, sc-40), PI3KC2α (BD Biosciences, Franklin Lakes, NJ, USA, #611046, Proteintech, Rosemont, IL, USA, 22028–1-AP, and Santa Cruz Biotechnology, sc-365290), Rb (Cell Signaling Technology, #9309), S6 (Cell Signaling Technology, #2217), phospho-S6 (Cell Signaling Technology, #4858), STMN1 (Cell Signaling Technology, #3352), TTC5 (Proteintech, 26112–1-AP), α-tubulin (Santa Cruz Biotechnology, sc-5286 and Cell Signaling Technology, #2144), β-tubulin (Sigma‒Aldrich, T8660), and γ-tubulin (Bethyl Laboratories, A302-631A). The ADMA5825 antibody, which recognizes CARM1 substrates, was obtained from Dr. Mark T. Bedford. The PI3KC2α-R175me2a antibody (AbClon, Seoul, Republic of Korea, AC230110-161) was generated in rabbits using asymmetrically dimethylated peptide (NH2-NGFNPR(me2a)MPTFP-COOH). HRP-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA, USA, 111–035-003 and 115–035-003).